Anand Surana is a key figure in the Indian pharmaceutical industry and, along with his brother Dilip, controls the Bangalore-headquartered generics firm, Micro Labs. His life is part of a family success story rooted in the South Indian pharmaceutical market.

The company was founded in 1973 in Chennai by his late father, G.C. Surana, who was a former pharmaceutical distributor. This upbringing, therefore, was defined by the rigorous, meticulous world of generics manufacturing, supply chain efficiency, and the critical importance of domestic drug distribution. While specific details about his academic career are private, his path led him into management and deep involvement in the family business early on, gaining crucial operational experience. The Surana family’s strength comes from their unified control over Micro Labs, which became a leading producer of essential drugs for cardiac diseases, diabetes, and pain management, making their wealth foundational to Indian healthcare.

Anand Surana’s career has been spent almost entirely within the structure of Micro Labs Limited, where he has served as a Whole-time Director and played a pivotal role alongside his brother Dilip in scaling the business into a multi-billion dollar enterprise. The company's strategy under their joint leadership focused on aggressive growth in the high-volume generics market, with nearly 60% of their annual revenue consistently generated from the critical domestic Indian market.

Beyond the core pharma business, Anand Surana has also diversified his interests into related fields and infrastructure, holding numerous directorships and designated partner roles in over 27 companies, including those focused on financial services, real estate development (DNR Buildcon, DNR Infracon), and infrastructure projects. This systematic diversification reflects a common strategy among Indian industrial billionaires to leverage core wealth into stable, asset-heavy sectors. His career is one of quiet, consistent growth, successfully navigating the complex regulatory environment of the pharmaceutical industry and ensuring the company's continuous technological and manufacturing upgrades, such as the recent factory built near Bangalore for pharma ingredients.

Anand Surana’s most profound social impact is through the core business of Micro Labs—the widespread production and distribution of affordable generic drugs in India and globally. This is a critical service that directly improves public health outcomes for millions of people who rely on cost-effective medications for chronic diseases.

While the Surana family is generally private about personal charitable endeavors, their corporate responsibility efforts are focused on the communities surrounding their manufacturing centers, often involving health and education initiatives. Their ongoing investment in large-scale domestic manufacturing, such as the major factory completion near Bangalore, creates thousands of jobs and strengthens India’s position as a global pharmaceutical manufacturing hub, representing a significant long-term economic and social contribution.

Anand Surana projects the image of a seasoned South Indian industrialist—disciplined, focused, and low-profile. His style is characterized by classic, high-quality business wear, often favoring light, tailored suits or high-end traditional Indian kurtas/bandhgalas appropriate for the corporate environment of Bangalore. He values discretion and efficiency, avoiding the excessive ostentation that sometimes accompanies new wealth.

His luxury is quiet, derived from his secure position within India's vital pharmaceutical sector. His residences in Bangalore reflect high-end comfort and privacy. His travel is primarily business-focused, overseeing manufacturing sites and global distribution networks. The ultimate marker of his affluence is the enduring stability of Micro Labs, which, as a privately held company, grants him complete control over a multi-billion dollar enterprise that touches the lives of millions through its essential products.